tiprankstipranks
Trending News
More News >

Towa Pharmaceutical Revises Financial Forecasts for FY 2025

Story Highlights
Towa Pharmaceutical Revises Financial Forecasts for FY 2025

Confident Investing Starts Here:

Towa Pharmaceutical Co ( (JP:4553) ) has shared an update.

Towa Pharmaceutical Co., Ltd. has revised its financial forecasts for the fiscal year ending March 31, 2025, reflecting a slight decrease in net sales and operating profit but a significant increase in ordinary profit and profit attributable to owners of the parent. The adjustments are attributed to foreign exchange gains, valuation of derivatives, and effective tax incentives, which have positively impacted the company’s financial outlook.

More about Towa Pharmaceutical Co

Towa Pharmaceutical Co., Ltd., headquartered in Kadoma, Osaka, is a company engaged in the pharmaceutical industry. It focuses on the development, production, and marketing of generic drugs, catering to a wide market that demands affordable medication options.

Average Trading Volume: 126,107

Technical Sentiment Signal: Hold

Current Market Cap: Yen129.8B

See more insights into 4553 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1